With the high incidence of cervical cancer, early screening for cervical cancer is becoming increasingly important. However, when it comes to cervical biopsies during screening, many people are worried about the risk of infection. This article will explain why it is not recommended to use reusable cervical biopsy forceps and why disposable ones are recommended.
Contact us to discuss your requirements of Disposable Biopsy Forceps. Our experienced sales team can help you identify the options that best suit your needs.
Since cervical biopsy is an invasive operation, it may cause obvious vaginal bleeding after the operation, and when the bleeding is significant, it may also cause anemia. After the biopsy, inflammation of the cervix may occur, and it may even lead to pelvic inflammatory disease or vaginal inflammation. Therefore, for cervical biopsies, sterile disposable biopsy must be used in strict accordance with disinfection standards. Prior to the biopsy, povidone-iodine solution should be used to disinfect the vulva and vagina to avoid unnecessary infection caused by the biopsy operation.
Cervical biopsy is a key indicator for diagnosing cervical cancer and precancerous lesions, and is one of the commonly used gynecological examination methods. With the high growth rate and incidence of cervical cancer, cervical biopsy is particularly important. Therefore, the sterile operation of single use biopsy forceps is even more stringent. Additionally, clinical studies in several large hospitals have shown that complete sterilization cannot be achieved, so it is recommended to use disposable cervical biopsy forceps.
The company is the world’s best Laparoscopic Instrument supplier. We are your one-stop shop for all needs. Our staff are highly-specialized and will help you find the product you need.
Compared with the reusable biopsy forceps currently used in hospitals, disposable cervical biopsy forceps can completely eliminate hospital-acquired infections. They have a larger operating space and a greater market potential. With the increasing incidence and younger age of cervical cancer, a normal tertiary hospital performs 30,000 to 40,000 biopsies annually, and single use biopsy forceps will gradually replace the traditional reusable ones, bringing higher revenue and considerable profits to the hospital.
From the perspective of clinical doctors and gynecology directors, using single use biopsy forceps is more convenient, thoroughly eliminates hospital-acquired infections, effectively reduces biopsy bleeding, and alleviates pain. At the same time, it can bring more economic benefits to the department.
Cervical cancer is one of the most common malignant tumors in women. Through screening, it can be detected early, treated early, and improve the treatment effect to save lives. Screening can detect precancerous lesions of the cervix, and after treatment, the occurrence of cancer can be reduced. For patients, their focus is on their own safety rather than the cost, so they buy peace of mind, health, and safety.
Despite the prevailing emphasis on falling reimbursements and cost containment, the use of disposable endoscopic accessories has grown tremendously. They offer simplicity of use, certain sterility, and reduced labor costs in exchange for higher purchase costs per procedure and the burden of waste disposal. Disposable accessories provide greater variety, complexity, and utility. They carry a cost burden that may be acceptable when the devices are difficult to reprocess, when they incorporate features that justify the added cost, or when their unit cost approaches purchase plus reprocessing costs for reusable alternatives, such as for biopsy forceps. Units with small volumes may prefer the ease of disposable accessories independent of relative cost issues, while large high-volume units may need to evaluate cost data more carefully to maintain sustainable practices.
Want more information on Disposable Trocar? Feel free to contact us.